Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash $ 95,296 $ 90,173
Accounts receivable 6,972
Prepaid expenses and other current assets 21,000 21,000
Total current assets 123,268 111,173
Property Plant and Equipment, net 9,767 1,064
Patents, net 4,338,272 4,500,000
Total assets 4,471,307 4,612,237
Current Liabilities    
Accounts payable and accrued expenses 2,991,510 2,714,041
Short term advances 20,323
Notes payable, net of discounts of $1,839,636 as of March 31, 2018 and $2,624,984 as of December 31, 2017 5,191,387 4,461,160
Notes payable - related parties 270,000 270,000
Derivative liability 3,818,907 5,939,600
Current portion of long term loan 1,064 4,221
Total current liabilities 12,272,868 13,409,345
Series C preferred stock liability, net of discounts of $94,000 at March 31, 2018 and $101,808 as of December 31, 2017 665,999 598,192
Acquisition payable 155,000 155,000
Total liabilities 13,093,867 14,162,537
COMMITMENTS AND CONTINGENCIES
Shareholders’ deficit    
Super AA super voting preferred stock, $0.001 par value; 1,000,000 authorized and 5,000 and 5,000 issued and outstanding at March 31, 2018 and December 31, 2017 5 5
Series B convertible preferred stock, $0.0001 par value; 50,000 shares authorized, 1,350 and 0 issued and outstanding at March 31, 2018 and December 31, 2017 1
Common stock, $0.0001 par value;  500,000,000 shares authorized; 337,958,062 and 316,951,712 shares issued  and outstanding as of March 31, 2018 and December 31, 2017 33,793 31,692
Additional paid-in capital 21,148,571 19,604,016
Stock subscriptions (1,570) (1,570)
Accumulated deficit (29,803,360) (29,184,443)
Total shareholders’ deficit (8,622,560) (9,550,300)
Total liabilities and shareholders’ deficit $ 4,471,307 $ 4,612,237